|
BTI
|
2
|
Resverlogix Corp.
|
Nov 23, 2015 11:25AM
|
|
Re: PAH article
|
2
|
Resverlogix Corp.
|
Jun 07, 2020 07:39AM
|
|
Re: Worst Communicating Company in History?
|
2
|
Zenith Epigenetics
|
Jun 10, 2017 04:31PM
|
|
Re: Prostate Ca / Brd4
|
2
|
Zenith Epigenetics
|
Feb 21, 2019 03:28PM
|
|
The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 12:14PM
|
|
Re: Amarin 3 or 5 point MACE
|
2
|
Resverlogix Corp.
|
Feb 13, 2019 09:30AM
|
|
Re: A vs V
|
2
|
Resverlogix Corp.
|
Mar 29, 2019 07:59PM
|
|
Re: ASCO study...Celgene
|
2
|
Zenith Epigenetics
|
Jun 01, 2019 05:48PM
|
|
Re: ClinicalTrials.Gov updated....calling the science geeks
|
2
|
Resverlogix Corp.
|
Oct 21, 2017 08:09AM
|
|
Re: The Life Sciences Report Interview with George Zavoico (4/6/16)
|
2
|
Resverlogix Corp.
|
Apr 07, 2016 02:12PM
|
|
Re: The final events.....
|
2
|
Resverlogix Corp.
|
Jan 25, 2019 11:38AM
|
|
Q2 2016 Slide Deck from BIO International 2016
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 08, 2016 01:19PM
|
|
10/28/16 Financial Statement and MD&A on SEDAR
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2016 11:04PM
|
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
2
|
Resverlogix Corp.
|
Dec 05, 2016 04:13PM
|
|
Re: New presentation on the website
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 11, 2020 06:04PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Jun 01, 2019 07:32PM
|
|
Shire pulls the plug on MPS-III LSD candidate SHP610
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 02, 2016 10:30AM
|
|
Re: ... here's a thought...
|
2
|
Resverlogix Corp.
|
Mar 01, 2016 09:13AM
|
|
Re: Next News Release
|
2
|
Resverlogix Corp.
|
May 19, 2017 10:47AM
|
|
Resverlogix featured in Bio Business Magazine
|
2
|
Resverlogix Corp.
|
May 24, 2016 03:23PM
|
